Highlight Tx announces follow-up results from PIIb study of BO-112 + anti-PD1
13 Apr 2022 //
GLOBENEWSWIRE
Highlight Therapeutics to present at AACR 2022
14 Mar 2022 //
GLOBENEWSWIRE
Highlight & Pivotal advance into a Phase IIa trial to examine Gastro-Intestinal
21 Oct 2020 //
PHARMIWEB
Highlight trials second-line melanoma combo after immunotherapy fails
08 Sep 2020 //
PHAMAPHORUM
Highlight Therapeutics Announces Second Phase Oncology Collaboration with Merck
02 Sep 2020 //
GLOBENEWSWIRE